However, in the process of AD disease, excessive activation of downstream complement will lead to the production of C5a, which can bind with the receptor and cause a series of negative reactions such as inflammation, injury and neuronal death (Ager et al., 2010). Here, C5AR1 is linked to Alzheimer disease.